Sentonix
Arlington, US · Founded 2023 · Delaware corporation
Founders & leadership
KS
Karl SchmidtChief Operating Officer
JB
John BeaverChief Executive Officer
KT
Kenan TurnaciogluSecretary, Treasurer
Board
JH
Jack HoppinBoard director
Reported raises · per SEC filings
Form D private placements$19.2M disclosed across 2 rounds · 2024–2026
▶$12.7MraisedAug 2026 · 17 investors · PharmaceuticalsRule 506(b)
▶$12.7MraisedAug 2026 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Karl SchmidtExecutive Officer
- John BeaverExecutive Officer, Director
- Kenan TurnaciogluExecutive Officer, Director
- Jack HoppinDirector
- Offering amount
- $21.2M
- Amount sold
- $12.7M
- Minimum investment
- $250K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$6.5MraisedMay 2025 · 15 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedMay 2025 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Karl SchmidtExecutive Officer
- John BeaverExecutive Officer, Director
- Jack HoppinDirector
- Kenan TurnaciogluExecutive Officer, Director
- Offering amount
- $10.5M
- Amount sold
- $6.5M
- Minimum investment
- $10K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Sentonix raised?
- Sentonix has disclosed $19.2M raised across 2 rounds.
- Where is Sentonix headquartered?
- Sentonix is headquartered in Arlington, US.